A mouse model of systemic lupus erythematosus responds better to soluble TACI than to soluble BAFFR, correlating with depletion of plasma cells.
Haselmayer, Philipp
A mouse model of systemic lupus erythematosus responds better to soluble TACI than to soluble BAFFR, correlating with depletion of plasma cells. [electronic resource] - European journal of immunology 06 2017 - 1075-1085 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1521-4141
10.1002/eji.201746934 doi
Animals
Autoantibodies--biosynthesis
Autoimmunity
B-Cell Activating Factor--antagonists & inhibitors
B-Cell Activation Factor Receptor--administration & dosage
B-Lymphocytes--immunology
Disease Models, Animal
Flow Cytometry
Kidney--immunology
Lupus Erythematosus, Systemic--immunology
Mice
Plasma Cells--immunology
Transmembrane Activator and CAML Interactor Protein--administration & dosage
Tumor Necrosis Factor Ligand Superfamily Member 13--antagonists & inhibitors
A mouse model of systemic lupus erythematosus responds better to soluble TACI than to soluble BAFFR, correlating with depletion of plasma cells. [electronic resource] - European journal of immunology 06 2017 - 1075-1085 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1521-4141
10.1002/eji.201746934 doi
Animals
Autoantibodies--biosynthesis
Autoimmunity
B-Cell Activating Factor--antagonists & inhibitors
B-Cell Activation Factor Receptor--administration & dosage
B-Lymphocytes--immunology
Disease Models, Animal
Flow Cytometry
Kidney--immunology
Lupus Erythematosus, Systemic--immunology
Mice
Plasma Cells--immunology
Transmembrane Activator and CAML Interactor Protein--administration & dosage
Tumor Necrosis Factor Ligand Superfamily Member 13--antagonists & inhibitors